Loxapine Capsule
Product Images NDC 70518-0346

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Loxapine (NDC 70518-0346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy Label

This is a prescription medication that contains Loxapine in the form of capsules, with a strength of 5mg per capsule. The package contains 30 capsules and it should be stored at a temperature of 20-25°C. The medication is manufactured by Actavis and the source NDC is 00591-0369-01. Additionally, it has been repackaged by RemedyRepack Inc. The expiry and OT numbers are not available from the given text. The medication should be kept out of reach of children and directions for use should be followed as indicated in the package insert.*

FDA Label Image

The Structurla Formula Of Loxapine, A Dibenzoxazepine Compound, Represents A Subclass Of Tricyclic Antipsychotic Agents, Chemically Distinct From The Thioxanthenes, Butyrophenones, And Phenothiazines. (Image 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.